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Site-Directed Mutagenesis to Determine Key Amino Acid Residues in Cell Penetrating 
Peptides 
 The Freeman lab primarily focuses on the study of natural product biosynthesis, 
particularly in unique host organisms. Developing a protein transduction system will allow for 
the further study of natural product biosynthesis in a wide range of new organisms. The 
mechanism of protein transduction researched in this study is through the use of cell-penetrating 
peptides (CPPs) as carrier molecules. 
 CPPs are a class of molecule that are able to translocate across the cell membrane. As a 
result, they have the potential to be used as a carrier molecule to transport other proteins within 
the cell. They are typically 10-60 amino acids in size and are often positively charged.1 Short 
proline-rich antimicrobial peptides (PrAMPs), specifically apidaecin-type peptides, are a well-
studied class of cationic CPPs that penetrate the bacterial membrane without depolarizing it. 
Once inside the cell, the PrAMP binds to a subunit of the ribosome, inhibiting it from forming 
the full ribosome and thus halting protein translation, slowly causing the death of the cell.2 The 
antimicrobial activity of these CPPs presents problems for heterologous expression in 
Escherichia coli, the most widely used host microbe in research studies. This report looks at 
possible ways of using site-directed mutagenesis to decouple the antimicrobial properties of 
PrAMPs from the cell translocation properties in order to develop a simple and effective method 
of both heterologous expression of CPP fusion proteins and also use them to transport cargo into 
host cells. A split GFP reporter assay3 (small fragment attached to PrAMP, big fragment 
expressed in target cells) determined the cell penetration abilities of the PrAMP. Eight different 
single amino acid mutant PrAMP sequences were created and cloned into expression and cloning 
cells. Table 1 below shows each mutation as well as the entire sequence of the PrAMP that was 
mutated. 
Apidaecin Primary Sequence 
5’  GNNRPVYIPQPRPPHPRI  3’ 
Name Mutation 
M01 His15Ala 
M02 Arg4Ala 
M03 Pro5Ala 
M04 Ile8Ala 
M05 Gln10Ala 
M07 Tyr7Ala 
M08 Pro13Ala 
M09 Arg17Ala 
  
One mutant PrAMP was successfully expressed in E. coli and purified using sonication and 
affinity chromatography. 
Materials and Methods 
Cloning  
Alanine scanning was performed on the PrAMP using mutated PCR primers. Single 
amino acids were selected based on structural significance (charge, polarity, size) and mutated to 
Table 1: The top row shows the amino acid sequence of the PrAMP sequence that was mutated in 
this study, which was an apidaecin type PrAMP. The mutations that were constructed are also listed. 
alanine. PCR products were ligated into pETDuet plasmids and transformed into a cloning strain 
of E. coli (TOP10). Upon sequence verification, successful constructs were transformed into 
both cloning and expression cell lines. In total, eight different mutant PrAMPs were constructed. 
The entire construct contained an N-terminal SUMO tag to mask the PrAMP from the expression 
cells as well as make the protein more soluble, but then was cleaved before assaying. 
Protein Purification 
Overnight cultures of BL21 A1 expression cells were grown in LB+amp shaking cultures 
at 37C. A 10% inoculation was done into TB+amp cultures, which were grown to an OD600 of 
2.70 in a 37C shaker, at which point protein expression was induced with IPTG and 20% L-
arabinose. After three hours of growth cells were harvested by snap freezing in liquid nitrogen. 
Proteins were purified using sonication and standard Ni-NTA affinity chromatography using the 
N-terminal octa-histidine. After sonication in lysis buffer containing 50mM NaPhosphate, 
300mM NaCl, and 5mM imidazole, the protein was still insoluble, so the pellet was used for 
further purification. The pellet was then resuspended in the same lysis buffer above but with the 
addition of 0.1% triton-X100 to remove cell debris. This was centrifuged again and the pellet 
was resuspended in lysis buffer containing 6M urea and 25mM imidazole to unfold the protein 
and prevent non-specific binding to the Ni-NTA resin. After centrifugation, the supernatant was 
then used for the Ni-NTA affinity chromatography purification. Five elutions were performed 
using a buffer containing 250mM imidazole to displace the protein from the resin. Gel samples 
were collected at several steps to monitor the location of the protein throughout the purification 
process. After purification, proteins were concentrated by buffer exchange at 4C using a dialysis 
buffer containing 50mM NaPhosphate, 300mM NaCl, 5mM imidazole, 2mM TCEP, and 2mM 
MgCl2. After dialysis, protein was further purified using aquacide II sand at 4C.  
Results 
 Eight different mutant PrAMP sequences were created with single amino acid changes 
and verified using sequencing data. Each mutant constructed was cloned into a cloning and 
expression cell line. The M02 mutated PrAMP, shown in Table 1, was purified using affinity 
chromatography. The SUMO solubility tag was cleaved so that the final protein contained only 
the PrAMP attached to the little fragment of GFP. Figure 1 below shows the processing sequence 
the protein underwent. 
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Figure 1: The figure below shows the process of expression, purification, and cleavage of the M02 mutated apidaecin 
construct. Step 1 shows the entire construct that was expressed in BL21 A1 cells. This construct was purified using 
the standard Ni-NTA affinity chromatography purification using the octa-histidine tag. Step 2 shows the result of 
cleavage of the SUMO tag using the bdSENP1 protease, which cleaved immediately before the N-terminus of the 
CPP. Step 3 shows the result of a reverse purification, in which the SUMO tag was bound to Ni-NTA resin by the octa-
histidine tag, and the apidaecin M02 CPP + LilGFP peptide was collected in the flow-through.  
Gel samples were collected from the cell pellet and supernatant after the sonication and triton- 
X100 treatment steps, as well as from each elution. The gels are shown below in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The gels in Figure 2 show that the protein of interest in each case was in fact in the pellet in both 
the initial centrifugation and after the triton-X100 step, which is what was expected. It also 
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Figure 2: The gels below track the protein through the purification process. Samples were taken 
after sonication, triton-X100 treatment, and after each elution. Labels in bold text describe samples 
from Su001LilGFP M02 construct purification, while unbolded text labels indicate Su001Nint M02 
construct samples. The Su001Nint M02 construct is the same construct as the Su001LilGFP M02 
construct described in Figure 1 except with an N-terminal split intein replaced for the small GFP 
fragment. 
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shows that there was a lot of protein recovered in the first couple elutions, with less and less 
protein being purified with each consecutive elution. 
Conclusions 
 Several mutant apidaecin PrAMPs have now been cloned into expression cells. In the 
future, the rest of the mutated PrAMPs could be purified and tested for both cell penetration 
ability as well as antimicrobial activity. Mutations that hinder antimicrobial activity but maintain 
cell penetration could potentially be combined to create a PrAMP sequence that is able to 
penetrate the cell but then not kill the cell, making it a useful tool in delivering cargo including 
natural products and other peptides into the cell for further study. In this manner, it would be 
possible to study a single biosynthetic pathway using several different heterologous hosts 
because a simple method would be available to transfer all intermediates of the pathway to each 
host through the utilization of CPPs as carriers. 
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